Adverum Biotechnologies (ADVM) Misses Q3 EPS by 130c

Adverum Biotechnologies (NASDAQ: ADVM) reported Q3 EPS of ($1.30). Revenue for the quarter came in at $1 million.

For earnings history and earnings-related data on Adverum Biotechnologies (ADVM) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• Adobe (ADBE) PT Raised to $250 at Baird
• Allarity Therapeutics files SPAC registration for $100M IPO